Published in Am J Kidney Dis on May 20, 2011
Adherence to a healthy lifestyle and all-cause mortality in CKD. Clin J Am Soc Nephrol (2013) 1.64
Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol (2013) 1.63
Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One (2012) 1.01
Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond) (2012) 0.94
Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol (2014) 0.87
The preliminary effects of a primary care-based randomized treatment trial with overweight and obese young children and their parents. J Pediatr Health Care (2013) 0.87
Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease. BMC Nephrol (2015) 0.82
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2015) 0.82
Risk of Incident Coronary Heart Disease Events in Men Compared to Women by Menopause Type and Race. J Am Heart Assoc (2015) 0.81
The Association Between Body Mass Index and All-Cause Mortality in Patients With Type 2 Diabetes Mellitus: A 5.5-Year Prospective Analysis. Medicine (Baltimore) (2015) 0.81
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD. Clin J Am Soc Nephrol (2013) 0.81
Relationship between changes in body fat and a decline of renal function in the elderly. PLoS One (2014) 0.80
Body mass index and causes of death in chronic kidney disease. Kidney Int (2016) 0.80
Association of Body Mass Index with Clinical Outcomes in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Cardiorenal Med (2015) 0.78
Obesity and the epidemiology and prevention of kidney disease: waist circumference versus body mass index. Am J Kidney Dis (2011) 0.78
Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol (2012) 0.78
Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Curr Hypertens Rep (2015) 0.77
Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients. Nephrol Dial Transplant (2013) 0.77
Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity. Am J Nephrol (2016) 0.76
Waist circumference and mortality: is albuminuria the missing link? Am J Kidney Dis (2012) 0.75
Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010. PLoS One (2016) 0.75
Contextual poverty, nutrition, and chronic kidney disease. Adv Chronic Kidney Dis (2015) 0.75
Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service. BMC Nephrol (2016) 0.75
Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. Int J Obes (Lond) (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05
Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50
Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med (2002) 4.47
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr (2004) 2.37
Waist circumference and mortality. Am J Epidemiol (2008) 2.26
Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc (2005) 2.15
Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res (2003) 1.93
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol (2009) 1.86
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71
Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis (2008) 1.22
Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results. Kidney Int (2005) 1.13
The obesity epidemics in ESRD: from wasting to waist? Nephrol Dial Transplant (2008) 1.02
Obesity management in adults with CKD. Am J Kidney Dis (2009) 1.02
Can comprehensive lifestyle change alter the course of chronic kidney disease? Semin Nephrol (2009) 0.93
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med (2008) 9.95
Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med (2005) 8.95
Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med (2011) 8.54
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care (2011) 5.50
Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol (2011) 5.46
The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26
Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (2012) 4.25
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2005) 4.24
Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01
Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med (2006) 4.01
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77
Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev (2004) 3.74
New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care (2009) 3.73
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63
Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 3.62
Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52
Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med (2011) 3.49
Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med (2006) 3.38
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20
Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol (2010) 3.17
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07
Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06
Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol (2002) 3.04
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res (2011) 3.01
Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med (2008) 2.99
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med (2003) 2.94
Seasonal patterns in monthly hemoglobin A1c values. Am J Epidemiol (2005) 2.93
Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol (2004) 2.91
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) (2012) 2.85
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol (2008) 2.68
Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care (2009) 2.58
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51
Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol (2005) 2.49
Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol (2002) 2.43
Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study. Ann Intern Med (2015) 2.42
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med (2004) 2.42
Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care (2010) 2.38
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35
Association between LDL-C and risk of myocardial infarction in CKD. J Am Soc Nephrol (2013) 2.34
Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol (2006) 2.32
Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32
High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Arch Intern Med (2006) 2.32
Missed dialysis sessions and hospitalization in hemodialysis patients after Hurricane Katrina. Kidney Int (2009) 2.31
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25
Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med (2003) 2.22
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant (2009) 2.17
Effect of Hurricane Katrina on the mortality of dialysis patients. Kidney Int (2009) 2.16
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum (2008) 2.13
Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation (2005) 2.13
Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun (2008) 2.11
Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) (2007) 2.11
Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am (2009) 2.10
Association between marijuana exposure and pulmonary function over 20 years. JAMA (2012) 2.09
Survival advantage of black patients with kidney disease after acute myocardial infarction. Clin J Am Soc Nephrol (2006) 2.08
ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology (2014) 2.08
Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol (2009) 2.06
Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int (2003) 2.04
Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem (2009) 2.03
Factors associated with hypertension control in the general population of the United States. Arch Intern Med (2002) 2.01